Article

Lipid-Glycoadjuvant@AuNPs Inhibits Tumor Gowth and Regulates Tumor Microenvironments by Tumor-Specific CTL-Ferived IFNγ

2021-07-29

Abstract excerpt

Inducing tumor-specific T cell responses and regulating suppressive tumor microenvironments have been a challenge for effective tumor therapy. CpG (ODN), the Toll-like receptor 9 agonist, has been widely used as adjuvants of cancer vaccines to induce T cell responses. However, clinical benefits of CpG based tumor vaccine were limited primarily due to the poor targeting to lymph nodes. Here we developed a lipid-gly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 099f7547-27a0-56aa-879c-c2fa251eb5f3
DOI: 10.21203/rs.3.rs-746366/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lipid-Glycoadjuvant@AuNPs Inhibits Tumor Gowth and Regulates Tumor Microenvironments by Tumor-Specific CTL-Ferived IFNγDOI 10.21203/rs.3.rs-746366/v1Read

Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen LoadingSemantic proximity Read

Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.Semantic proximity Read

Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapySemantic proximity Read

Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.Semantic proximity Read

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read

Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer ImmunotherapySemantic proximity Read

Anti-PD-1-iRGD Peptide Conjugate Boosts Antitumor Efficacy via Engagement Augmentation and Penetration Enhancement of T cellsSemantic proximity Read

Self-Assembled Tetrahedral Framework Nucleic Acid Mediated Tumor-Associated Macrophages Reprogramming and Enhancing Cancer ImmunotherapySemantic proximity Read

Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects.Semantic proximity Read

Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor modelSemantic proximity Read

In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapySemantic proximity Read

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineSemantic proximity Read